The effect of iron in MRI and transverse relaxation of amyloid‐beta plaques in Alzheimer's disease
暂无分享,去创建一个
Qing X Yang | Qing X. Yang | Rahul P Dewal | J. Connor | Mark D. Meadowcroft | Douglas G. Peters | James R Connor | R. Dewal | Mark D Meadowcroft | Douglas G Peters
[1] Christian Denk,et al. Susceptibility weighted imaging with multiple echoes , 2010, Journal of magnetic resonance imaging : JMRI.
[2] C. Jenkins,et al. Evidence of redox-active iron formation following aggregation of ferrihydrite and the Alzheimer's disease peptide β-amyloid. , 2014, Inorganic chemistry.
[3] Paul M Thompson,et al. Regional differences in white matter breakdown between frontotemporal dementia and early-onset Alzheimer's disease. , 2014, Journal of Alzheimer's disease : JAD.
[4] Louise van der Weerd,et al. MRI artifacts in human brain tissue after prolonged formalin storage , 2011, Magnetic resonance in medicine.
[5] Steven M LeVine,et al. Iron deposits in multiple sclerosis and Alzheimer's disease brains , 1997, Brain Research.
[6] W. Moses. Fundamental Limits of Spatial Resolution in PET. , 2011, Nuclear instruments & methods in physics research. Section A, Accelerators, spectrometers, detectors and associated equipment.
[7] J. Kwiatkowski. Real-world use of iron chelators. , 2011, Hematology. American Society of Hematology. Education Program.
[8] Bejoy Thomas,et al. Principles, techniques, and applications of T2*-based MR imaging and its special applications. , 2009, Radiographics : a review publication of the Radiological Society of North America, Inc.
[9] Clifford R. Jack,et al. Regional differences in MRI detection of amyloid plaques in AD transgenic mouse brain , 2011, NeuroImage.
[10] G. van der Laan,et al. Ferrous iron formation following the co-aggregation of ferric iron and the Alzheimer's disease peptide β-amyloid (1–42) , 2014, Journal of The Royal Society Interface.
[11] J. Connor,et al. Iron, brain ageing and neurodegenerative disorders , 2004, Nature Reviews Neuroscience.
[12] Yi Liu,et al. Change in knee cartilage T2 at MR imaging after running: a feasibility study. , 2005, Radiology.
[13] J. D. Robertson,et al. Copper, iron and zinc in Alzheimer's disease senile plaques , 1998, Journal of the Neurological Sciences.
[14] M. D'Andrea,et al. Lipofuscin and Aβ42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains , 2002, Neuroscience Letters.
[15] J. Connor,et al. A histochemical study of iron, transferrin, and ferritin in Alzheimer's diseased brains , 1992, Journal of neuroscience research.
[16] R. Scott,et al. Is hemochromatosis a risk factor for Alzheimer's disease? , 2001, Journal of Alzheimer's disease : JAD.
[17] Xiongwei Zhu,et al. Alzheimer disease: evidence for a central pathogenic role of iron-mediated reactive oxygen species. , 2004, Journal of Alzheimer's disease : JAD.
[18] G. Bartzokis. Alzheimer's disease as homeostatic responses to age-related myelin breakdown , 2011, Neurobiology of Aging.
[19] G. Perry,et al. Metabolic, metallic, and mitotic sources of oxidative stress in Alzheimer disease. , 2000, Antioxidants & redox signaling.
[20] C. Masters,et al. Iron-Export Ferroxidase Activity of β-Amyloid Precursor Protein Is Inhibited by Zinc in Alzheimer's Disease , 2010, Cell.
[21] G. Perry,et al. Three-dimensional tomographic imaging and characterization of iron compounds within Alzheimer's plaque core material. , 2008, Journal of Alzheimer's disease : JAD.
[22] J. Dobson,et al. Redox cycling of iron by Abeta42. , 2006, Free radical biology & medicine.
[23] G. Fullerton,et al. The influence of macromolecular polymerization of spin-lattice relaxation of aqueous solutions. , 1987, Magnetic resonance imaging.
[24] P. Faller,et al. Iron(II) binding to amyloid-β, the Alzheimer's peptide. , 2011, Inorganic chemistry.
[25] J. Dobson,et al. Redox cycling of iron by Aβ42 , 2006 .
[26] W. Koppenol. The Haber-Weiss cycle – 70 years later , 2001, Redox report : communications in free radical research.
[27] G. Robino,et al. H2o2 and 4-hydroxynonenal mediate amyloid β-induced neuronal apoptosis by activating jnks and p38mapk , 2003, Experimental Neurology.
[28] M. D'Andrea,et al. Lipofuscin and Abeta42 exhibit distinct distribution patterns in normal and Alzheimer's disease brains. , 2002, Neuroscience letters.
[29] Joseph A. Helpern,et al. Histological Co-Localization of Iron in Aß Plaques of PS/APP Transgenic Mice , 2005, Neurochemical Research.
[30] Ryan Chamberlain,et al. Magnetic resonance imaging of amyloid plaques in transgenic mouse models of Alzheimer's disease. , 2011, Current medical imaging reviews.
[31] G. Perry,et al. Iron accumulation in Alzheimer disease is a source of redox-generated free radicals. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[32] Q. Pankhurst,et al. Preliminary evaluation of nanoscale biogenic magnetite in Alzheimer's disease brain tissue , 2003, Proceedings of the Royal Society of London. Series B: Biological Sciences.
[33] Qing X Yang,et al. MRI and histological analysis of beta‐amyloid plaques in both human Alzheimer's disease and APP/PS1 transgenic mice , 2009, Journal of magnetic resonance imaging : JMRI.
[34] B. Hallgren,et al. THE EFFECT OF AGE ON THE NON‐HAEMIN IRON IN THE HUMAN BRAIN , 1958, Journal of neurochemistry.
[35] Jan Sedlacik,et al. Susceptibility weighted imaging at ultra high magnetic field strengths: Theoretical considerations and experimental results , 2008, Magnetic resonance in medicine.
[36] J. Kehrer. The Haber-Weiss reaction and mechanisms of toxicity. , 2000, Toxicology.
[37] Jian Wang,et al. Regulation of cellular iron metabolism , 2011, The Biochemical journal.
[38] Roberto Cappai,et al. Metals and amyloid‐β in Alzheimer's disease , 2005, International journal of experimental pathology.
[39] Tobias Jung,et al. Lipofuscin-bound iron is a major intracellular source of oxidants: role in senescent cells. , 2010, Free radical biology & medicine.
[40] D. Harman,et al. Alzheimer's Disease Pathogenesis , 2006, Annals of the New York Academy of Sciences.
[41] F. Torti,et al. Response to Oxidative Stress Translational Regulation of Ferritin in Coordinate Transcriptional and , 2000 .
[42] Christopher M Collins,et al. Direct magnetic resonance imaging of histological tissue samples at 3.0T , 2007, Magnetic resonance in medicine.
[43] Mark A. Smith,et al. In Situ Oxidative Catalysis by Neurofibrillary Tangles and Senile Plaques in Alzheimer’s Disease , 2000, Journal of neurochemistry.
[44] Xudong Huang,et al. The A beta peptide of Alzheimer's disease directly produces hydrogen peroxide through metal ion reduction. , 1999, Biochemistry.
[45] W. Klein,et al. Iron Levels Modulate α‐Secretase Cleavage of Amyloid Precursor Protein , 1995, Journal of neurochemistry.
[46] W. Markesbery,et al. Oxidative damage in mild cognitive impairment and early Alzheimer's disease , 2007, Journal of neuroscience research.
[47] Michael Garwood,et al. In vivo visualization of Alzheimer's amyloid plaques by magnetic resonance imaging in transgenic mice without a contrast agent , 2004, Magnetic resonance in medicine.
[48] A. Bush. Metal complexing agents as therapies for Alzheimer’s disease , 2002, Neurobiology of Aging.